Name | Description | Size | Catalog # | Supplier | |
---|---|---|---|---|---|
88255-01-0 | Purity ≥98%. MW: 420.46 | 100 mg, 500 mg | MBS132338 |
MYBIOSOURCE INC. |
More Info |
95343-20-7 | Purity ≥98%. MW: 664.1 | 100 mg, 500 mg | MBS130215 |
MYBIOSOURCE INC. |
More Info |
1360900-71-5 | MW: 228.0427 | 100 mg | orb1146568 |
BIORBYT LTD. |
More Info |
666-15 | MW: 620.52 | 100 mg, 250 mg, 1 g | orb401883 |
BIORBYT LTD. |
More Info |
92.1 | Tissue: uvea; Tumor: melanoma, melanin production. | 1 vial | ABC-TC444S |
ACCEGEN BIOTECH |
More Info |
380 | Tissue: peripheral blood; Tumor: leukemia, pre-B cell; Derived from a pati… | 1 vial | ABC-TC442S |
ACCEGEN BIOTECH |
More Info |
1301 | Human T-cell leukaemia. 1301 Is a sub-line of CCRF-CEM. It has unusually l… | 1 vial | ABC-TC0001 |
ACCEGEN BIOTECH |
More Info |
5637 | 5637 Cell line was established from the primary bladder carcinoma of a 68-… | 1 vial | ABC-TC0015 |
ACCEGEN BIOTECH |
More Info |
666-15 | An inhibitor of CREB-mediated gene transcription (IC50 = 81 nM in a cell-b… | 10 mg | 30780-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
666-15 | An inhibitor of CREB-mediated gene transcription (IC50 = 81 nM in a cell-b… | 25 mg | 30780-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
666-15 | An inhibitor of CREB-mediated gene transcription (IC50 = 81 nM in a cell-b… | 5 mg | 30780-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
666-15 | An inhibitor of CREB-mediated gene transcription (IC50 = 81 nM in a cell-b… | 50 mg | 30780-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
293 | n/a | n/a | 103 |
NIH AIDS REAGENT PROGRAM |
More Info |
A 205804 | Purity ≥98%. MW: 300.39 | 100 mg, 500 mg | MBS132392 |
MYBIOSOURCE INC. |
More Info |
A 66 | Purity ≥98%. MW: 393.52 | 100 mg, 500 mg | MBS132169 |
MYBIOSOURCE INC. |
More Info |
A 740003 | Purity ≥98%. MW: 474.565 | 100 mg, 500 mg | MBS132187 |
MYBIOSOURCE INC. |
More Info |
A 740003 | Purity >98%. A 740003 is a novel competitive antagonist of P2X7 receptors… | 10 mg, 25 mg, 50 mg | MBS384091 |
MYBIOSOURCE INC. |
More Info |
A 769662 | Purity ≥98%. MW: 360.39 | 100 mg, 500 mg | MBS130892 |
MYBIOSOURCE INC. |
More Info |
A 769662 | Purity 97%+. MW: 360.39 | 5 mg, 1ml/10mM (in DMSO), 10 mg | MBS576261 |
MYBIOSOURCE INC. |
More Info |
A 803467 | Purity >98%. A 803467 is a selective blocker of NaV1.8 channels (IC50 valu… | 10 mg, 1 mL (in DMSO), 25 mg | MBS384093 |
MYBIOSOURCE INC. |
More Info |
A 83-01 | Purity ≥98% by HPLC. Background: A selective inhibitor of TGF-beta type… | 1 mg | MBS842636 |
MYBIOSOURCE INC. |
More Info |
A 83-01 | Purity ≥98%. MW: 421.52 | 100 mg, 500 mg | MBS132328 |
MYBIOSOURCE INC. |
More Info |
A 83-01 | Purity >98%. A83-01 is a TGF-β kinase / activin receptor like kinase… | 5 mg, 10 mg, 25 mg | MBS384095 |
MYBIOSOURCE INC. |
More Info |
A 922500 | MW: 428.48 | 5 mg | MBS8506458 |
MYBIOSOURCE INC. |
More Info |
A 922500 | Purity ≥98%. MW: 428.488 | 100 mg, 500 mg | MBS130245 |
MYBIOSOURCE INC. |
More Info |